5th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation

22 - 23 October 2012, Athens, Greece.
Cancer is a natural phenomenon and as such it should be amenable to mathematical and computational description. Clinically driven complex multiscale cancer models can produce rather realistic spatio-temporal simulations of concrete clinical interventions such as radio-chemotherapy applied to individual patients.

Clinical data processing procedures and computer technologies play an important role in this context. Following clinical adaptation and validation within the framework of clinico-genomic trials, models are expected to enhance individualized treatment optimization. The latter constitutes the long term goal of the emergent scientific, technological and medical discipline of in silico oncology.

Treatment optimization is to be achieved through experimentation in silico i.e. on the computer. Moreover, provision of insight into tumour dynamics and optimization of clinical trial design and interpretation constitute short- and mid-term goals of this new domain. Researchers working either in the area of in silico oncology or in the broader cancer research domain yet with an interest in computational oncology are invited to submit short papers.

The workshop is meant to be an excellent opportunity for both shaping and advancing the discipline.

Organizing Committee

  • G. Stamatakos, PhD, ICCS - National Technical University of Athens (GR), General Chair
  • Ν. Graf, MD, University Clinic of Saarland (DE)
  • K. Marias, PhD, Foundation for Research and Technology, Hellas (GR)
  • M. Akay, PhD, University of Houston (USA)
  • R.Radhakrishnan, PhD, University of Pennsylvania (USA)
  • D. Dionysiou, PhD, ICCS - National Technical University of Athens (GR)
  • V. Sakkalis, PhD, Foundation for Research and Technology - Hellas (GR)
  • N. Uzunoglu, PhD, ICCS - National Technical University of Athens (GR)

Important Dates
Paper submissions due: September 1, 2012.
Notification of acceptance: September 21, 2012. Camera ready papers due: September 30, 2012.

This year the 5th International Αdvanced Research Workshop on In Silico Oncology and Cancer Investigation will also be the TUMOR project workshop.

The TUMOR project aims at developing a European clinically oriented semantic-layered cancer digital model repository from existing EU projects that will be interoperable with the US grid enabled semantic-layered digital model repository platform at CViT.org (Center for the Development of a Virtual Tumor, Massachusetts General Hospital (MGH), Boston, USA) which is NIH/NCI-caGRID compatible.

For further information, please visit:
http://www.5th-iarwisoci.iccs.ntua.gr

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...